PROLOR Biotech, Inc.·4

Feb 6, 5:04 PM ET

HAVRON ABRAHAM 4

4 · PROLOR Biotech, Inc. · Filed Feb 6, 2013

Insider Transaction Report

Form 4
Period: 2013-02-04
HAVRON ABRAHAM
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2013-02-04+320,000320,000 total
    Exercise: $4.74Exp: 2023-02-04Common Stock (320,000 underlying)
  • Award

    Common Stock

    2013-02-04+100,000345,643 total
Footnotes (1)
  • [F1]Option vests in twelve equal monthly installments commencing on March 4, 2013.

Documents

1 file
  • 4
    v334027_4.xmlPrimary

    OWNERSHIP DOCUMENT